12K views · 459 reactions | Sputnik V is the world’s first registered human adenovirus vector-based COVID-19 vaccine developed by the Gamaleya Center in Russia. The human adenovirus vector platform has been studied over the decades and proven to be safe. Sign up for updates at sputnikvaccine.com | Sputnik V | Facebook

7.8K views · 294 reactions | Safety, speed, reliability, and quality control are key for vaccine deliveries around the world. Find out how we do it at #SputnikV in the new episode of Sputnik V Story with Daria Egorova - senior scientist from the Gamaleya Center, the vaccine developer. | Sputnik V | Facebook